Dare Bioscience, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Dare Bioscience, Inc. on April 22, 2019. The report serves as a current notification regarding the scheduling of the Company's 2019 annual meeting of stockholders.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance events and does not contain financial performance data.
Material Changes
There are no material financial changes reported in this filing. The primary event is the advancement of the 2019 annual meeting date to June 13, 2019, which is more than 20 days earlier than the first anniversary of the 2018 annual meeting.
Guidance, Outlook, and Corporate Events
- Annual Meeting Date: June 13, 2019.
- Stockholder Notice Deadline: Due to the advanced meeting date, written notices from stockholders regarding business proposals or director nominations must be received by the Company's Secretary no later than the close of business on May 2, 2019.
- Compliance: All notices must comply with the Company's by-laws and applicable SEC rules for inclusion in proxy materials.
Key Facts for Investor Verification
- Verify the May 2, 2019 deadline for submitting stockholder proposals or director nominations.
- Confirm the June 13, 2019 date for the 2019 annual meeting of stockholders.
- Note that this filing contains no financial results; refer to the most recent 10-Q or 10-K for financial data.